When analysing the genotype and allele distribution of TEP1 rs1760904, rs1713418 and TERC rs12696304, no statistically significant differences were found between MS patients younger than 44 years and the control group (p > 0.05). This evidence concerns the gene TEP1 and myeloid sarcoma.